Edition:
United Kingdom

People: Avadel Pharmaceuticals PLC (AVDL.OQ)

AVDL.OQ on NASDAQ Stock Exchange Global Market

3.19USD
14 Jun 2019
Change (% chg)

$0.54 (+20.38%)
Prev Close
$2.65
Open
$2.86
Day's High
$3.58
Day's Low
$2.80
Volume
348,557
Avg. Vol
58,152
52-wk High
$7.96
52-wk Low
$1.03

Thompson, Phillandas 

Mr. Phillandas T. Thompson serves as Senior Vice President, General Counsel, Corporate Secretary of the Company. He has been Senior Vice President and General Counsel of Avadel since November 2013. Before joining Avadel, Mr. Thompson was employed from January 2012 until November 2013 at West-Ward Pharmaceutical Corp. as Vice President, Legal Affairs, from January 2010 until November 2011 at Paddock Laboratories, Inc. as Vice President, General Counsel, from April 2006 until January 2010 at KV Pharmaceutical Co as Vice President, Strategic Business Transactions and Assistant General Counsel, and from October 2002 until March 2006 at Barr Laboratories, Inc. as Associate General Counsel. Prior to his employment with Barr Laboratories, Mr. Thompson was a corporate associate at White & Case, LLP. Mr. Thompson is a member of the New York Bar, the Missouri Bar, and the Minnesota Bar and has several other professional affiliations. Mr. Thompson earned a B.A. from Washington University in St. Louis and is also a graduate of the University of Michigan Law School (Juris Doctor) and the University of Michigan Business School (Master of Business Administration).

Basic Compensation

Total Annual Compensation, USD 1,002,900
Restricted Stock Award, USD 459,000
Long-Term Incentive Plans, USD --
All Other, USD 19,600
Fiscal Year Total, USD 1,481,500

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --